Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02981303
Title Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Biothera
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Arizona Center for Cancer Care Avondale Arizona 85392 United States Details
John Wayne Cancer Institute Santa Monica California 90404 United States Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
Sarah Cannon Research Institute Denver Colorado 80218 United States Details
University Cancer and Blood Center Athens Georgia 30607 United States Details
Piedmont Cancer Institute Atlanta Georgia 30318 United States Details
Stony Brook University Cancer Center Stony Brook New York 11794 United States Details
Thomas Jefferson University Sidney Kimmel Cancer Center Philadelphia Pennsylvania 19107 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Millennium Oncology Houston Texas 77090 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field